Macroview Investment Management LLC
- SEC CIK
- 0001551727
- Latest filing
- Jul 28, 2026
The latest 13F from Macroview Investment Management LLC covers Q2 2026 (filed Jul 28, 2026): 105 long positions worth $161.0M. The top 10 holdings make up 42.4% of the portfolio, and the largest is SPDR S&P 500 ETF Trust (SPY) at 6.6%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 15
- Est. +$7.71M
- Added
- 51
- Est. +$4.90M
- Reduced
- 30
- Est. −$3.31M
- Sold out
- 8
- Est. −$3.02M
Top 5 holdings
Share of this quarter's portfolio value
- SPYSPDR S&P 500 ETF Trust
- Innovator ETFs Trust45782C3915.0%$7.97M
- Schwab U.S. Large-Cap Growth ETF8085243004.7%$7.58M
- iShares MSCI Eafe ETF4642874654.4%$7.02M
- Invesco QQQ Trust Series I46090E1033.9%$6.26M
Share of portfolio
Top 5 holdings and the other 100 positions, by share of portfolio value
- SPY6.6%
- Innovator ETFs Trust5.0%
- Schwab U.S. Large-Cap Growth ETF4.7%
- iShares MSCI Eafe ETF4.4%
- Invesco QQQ Trust Series I3.9%
- Other 100 positions75.5%
Biggest buys
New and added positions, by estimated amount bought
Largest weight increases
New and added positions, by percentage points of the portfolio gained
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $161.0M
- +$17.7M (+12.4%) vs. prior quarter
- Positions
- 105
- +7 vs. prior quarter
- Top 10 concentration
- 42.4%
- Top 10 as share of value
- Turnover
- 4.2%
- Q2 2026, one quarter
- Average holding period
- 16.5 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $161.0M (Q2 2026)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 28, 2026 | 105 | $161.0M | SPYInnovator ETFs TrustSchwab U.S. Large-Cap Growth ETF | vs. Q1 2026 | SEC |
| Q1 2026 | May 8, 2026 | 98 | $143.2M | SPYInnovator ETFs TrustPHYS | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 5, 2026 | 96 | $145.3M | SPYInnovator ETFs TrustSchwab U.S. Large-Cap Growth ETF | vs. Q3 2025 | SEC |
| Q3 2025 | Oct 24, 2025 | 92 | $133.1M | Schwab U.S. Large-Cap Growth ETFInnovator ETFs TrustPHYS | vs. Q2 2025 | SEC |
| Q2 2025 | Jul 22, 2025 | 93 | $122.0M | Innovator ETFs TrustSchwab U.S. Large-Cap Growth ETFiShares MSCI Eafe ETF | vs. Q1 2025 | SEC |
| Q1 2025 | Apr 29, 2025 | 83 | $106.1M | Innovator ETFs TrustSchwab U.S. Large-Cap Growth ETFVanguard Scottsdale FDS | vs. Q4 2024 | SEC |
| Q4 2024 | Jan 31, 2025 | 79 | $98.5M | SPYiShares Core S&P 500 ETFSchwab U.S. Large-Cap Growth ETF | vs. Q3 2024 | SEC |
| Q3 2024 | Oct 22, 2024 | 584 | $102.2M | SPYHDSchwab U.S. Large-Cap Growth ETF | vs. Q2 2024 | SEC |
| Q2 2024 | Jul 23, 2024 | 586 | $93.7M | SPYSchwab U.S. Large-Cap Growth ETFHD | vs. Q1 2024 | SEC |
| Q1 2024 | Apr 30, 2024 | 634 | $90.2M | HDiShares Core S&P 500 ETFPHYS | vs. Q4 2023 | SEC |
| Q4 2023 | Jan 30, 2024 | 619 | $83.8M | HDPHYSiShares Core S&P 500 ETF | vs. Q3 2023 | SEC |
| Q3 2023 | Oct 26, 2023 | 801 | $74.4M | HDPHYSiShares Tr | vs. Q2 2023 | SEC |
| Q2 2023 | Jul 14, 2023 | 500 | $65.1M | PHYSiShares TriShares Core MSCI Eafe ETF | vs. Q1 2023 | SEC |
| Q1 2023 | Apr 18, 2023 | 451 | $62.4M | PHYSiShares TriShares Core MSCI Eafe ETF | vs. Q4 2022 | SEC |
| Q4 2022 | Jan 11, 2023 | 459 | $58.3M | PHYSiShares TrJanus Detroit STR Tr | vs. Q3 2022 | SEC |
| Q3 2022 | Oct 21, 2022 | 441 | $54.8M | iShares TrPHYSJanus Detroit STR Tr | vs. Q2 2022 | SEC |
| Q2 2022 | Jul 20, 2022 | 474 | $60.0M | PHYSiShares TriShares Core MSCI Eafe ETF | vs. Q1 2022 | SEC |
| Q1 2022 | May 2, 2022 | 456 | $69.6M | iShares TrPHYSiShares Core MSCI Eafe ETF | vs. Q4 2021 | SEC |
| Q4 2021 | Jan 25, 2022 | 413 | $77.9M | iShares TriShares Core MSCI Eafe ETFPHYS | vs. Q3 2021 | SEC |
| Q3 2021 | Oct 28, 2021 | 407 | $76.9M | iShares TrJanus Detroit STR TriShares Core MSCI Eafe ETF | vs. Q2 2021 | SEC |
| Q2 2021 | Jul 23, 2021 | 406 | $74.0M | Janus Detroit STR TriShares TrPHYS | vs. Q1 2021 | SEC |
| Q1 2021 | May 3, 2021 | 377 | $69.4M | Janus Detroit STR TrPIMCO Enhanced Short Maturity Active Exchange-Traded FundPHYS | – | SEC |